Related Experiment Video
Updated: May 5, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
The osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the kidney
1Diabetes Centre, A.S.S. 1 Triestina, Trieste, Italy.
Purpose Of Review:
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a cytokine belonging to the TNF superfamily. TRAIL may modulate cell survival and proliferation through interaction with two different receptors, TRAIL-R1 and TRAIL-R2. The actions of TRAIL are regulated by three decoy receptors, TRAIL-R3, TRAIL-R4 and osteoprotegerin (OPG). There is evidence that both TRAIL and OPG are expressed by renal cells. The OPG/TRAIL axis has been recently linked to the pathogenesis of renal damage and, in particular, diabetic nephropathy.
Recent Findings:
In patients with kidney diseases, serum TRAIL and OPG levels are increased in parallel and are significantly associated with each other. In diabetic nephropathy, the renal expression of TRAIL and OPG is elevated, and in tubular cells proinflammatory cytokines enhance TRAIL expression. Additionally, a high-glucose microenvironment sensitizes tubular cells to apoptosis induced by TRAIL, whereas OPG counteracts the actions of TRAIL in cultured cells.
Summary:
It seems that the expression and levels of TRAIL and OPG at serum and kidney levels are crucial for the pathogenesis of kidney diseases, and in particular diabetic nephropathy. Although further studies are necessary to clarify the exact role of the OPG/TRAIL axis in the kidney, this system seems to hold promise to provide therapeutic approaches for the management of renal damage.
Video Abstract Available:
See the Video Supplementary Digital Content 1 (http://links.lww.com/CONH/A5).
Insights
The OPG/TRAIL axis is crucial in kidney diseases, especially diabetic nephropathy. Elevated levels of TRAIL and OPG in serum and kidneys contribute to renal damage, suggesting therapeutic potential.
Area of Science:
- Immunology
- Nephrology
- Molecular Biology
Background:
- The Tumor Necrosis Factor (TNF)-related apoptosis-inducing ligand (TRAIL) pathway involves receptors TRAIL-R1/R2 and decoy receptors TRAIL-R3/R4 and osteoprotegerin (OPG).
- Both TRAIL and OPG are expressed in renal cells.
- The OPG/TRAIL axis is implicated in kidney damage, particularly diabetic nephropathy.
Purpose of the Study:
- To review the role of the OPG/TRAIL axis in the pathogenesis of kidney diseases.
- To explore the association between TRAIL, OPG, and diabetic nephropathy.
Main Methods:
- Review of existing literature on TRAIL and OPG in renal disease.
- Analysis of serum and renal tissue expression levels.
- Investigation of cellular responses in high-glucose environments.
Main Results:
- Serum TRAIL and OPG levels are elevated and correlated in kidney disease patients.
- Renal expression of TRAIL and OPG is increased in diabetic nephropathy.
- High glucose sensitizes tubular cells to TRAIL-induced apoptosis, while OPG provides protection.
Conclusions:
- The OPG/TRAIL axis plays a significant role in kidney disease pathogenesis, notably diabetic nephropathy.
- Further research is needed to fully elucidate the OPG/TRAIL axis in the kidney.
- This axis represents a potential therapeutic target for managing renal damage.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
Acute Kidney Injury II: Pathophysiology
The Intrinsic Apoptotic Pathway
TGF - β Signaling Pathway

